Besides, γh2A staining also suggested that the down-regulation of AKT1 sensitizes the cells to DNA damage, while up-regulate AKT1 resist the resists the cells to DNA damage, and it is an important occurrence in mediating the efficacy of Emodin in BC treatment (Figures 7C, D). The gene discussed is AKT1; the disease is breast cancer.